Literature DB >> 8468143

[Intravenous drug addiction and the risk of HIV infection in Madrid in 1990].

M V Zunzunegui Pastor1, M A Rodríguez Arenas, C Sarasqueta Eizaguirre.   

Abstract

As part of a multicenter WHO study on HIV infection among drug injectors, 472 intravenous drug users (IDUs) were interviewed, 240 recruited in the streets and 232 at drug treatment centers. The objectives of the study were to assess the prevalence of HIV infection among IDUs of Madrid, to identify factors associated with risk reduction behaviors, such as the use of sterile syringes and condoms. Chi-square and logistic regression were used to test for differences and to estimate odds ratios. Prevalence of HIV infection among IDUs in Madrid was 50% (53% among those recruited in the street and 38% among those recruited at treatment centers). Forty five per cent of those interviewed were still sharing syringes. Out of the 315 sexually active subjects, only 22% reported using condoms always or almost always. These results suggest that a range of interventions should be implemented to promote change towards healthier behaviors, including syringe-exchange programs, methadone maintenance treatments and pre- and post-test counseling in those agencies which care for this population.

Entities:  

Mesh:

Year:  1993        PMID: 8468143     DOI: 10.1016/s0213-9111(93)71127-9

Source DB:  PubMed          Journal:  Gac Sanit        ISSN: 0213-9111            Impact factor:   2.139


  3 in total

1.  The AIDS epidemic among Spanish drug users: a birth cohort-associated phenomenon.

Authors:  J Castilla; M Pollán; G López-Abente
Journal:  Am J Public Health       Date:  1997-05       Impact factor: 9.308

2.  Widening social inequalities in mortality: the case of Barcelona, a southern European city.

Authors:  C Borrell; A Plasència; I Pasarin; V Ortún
Journal:  J Epidemiol Community Health       Date:  1997-12       Impact factor: 3.710

3.  Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors.

Authors:  G Barrio; L De La Fuente; C Toro; T M Brugal; V Soriano; F Gonzalez; M J Bravo; F Vallejo; T C Silva
Journal:  Epidemiol Infect       Date:  2006-09-28       Impact factor: 2.451

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.